MD Anderson and CureVac collaborate to develop mRNA cancer vaccines

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.

April 11, 2025

Vol.51 No.14

Clinical Roundup

NK cells complexed with bispecific antibody yield high response rates in lymphoma

A novel cell therapy approach using cord blood-derived natural killer cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory CD30-positive lymphomas, according to a new study from the University of Texas MD Anderson Cancer Center.

April 11, 2025

Vol.51 No.14

In Brief

MD Anderson breaks ground on new Houston-area cancer center

The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.

April 04, 2025

Vol.51 No.13

In Brief

Jeffrey Lee named chief medical executive at MD Anderson

Jeffrey E. Lee was appointed chief medical executive at The University of Texas MD Anderson Cancer Center, effective April 1.

March 28, 2025

Vol.51 No.12

Capitol Hill

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Amid the flood zone of today’s Washington, the confirmation hearing for Jayanta (Jay) Bhattacharya’s nomination as director of NIH was remarkably calm.

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.

March 07, 2025

Vol.51 No.09

By Claire Marie Porter

MD Anderson and CureVac collaborate to develop mRNA cancer vaccines

YOU MAY BE INTERESTED IN

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

NK cells complexed with bispecific antibody yield high response rates in lymphoma

MD Anderson breaks ground on new Houston-area cancer center

Jeffrey Lee named chief medical executive at MD Anderson

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Renew today!

Subscriber content

MD Anderson and CureVac collaborate to develop mRNA cancer vaccines

YOU MAY BE INTERESTED IN

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

NK cells complexed with bispecific antibody yield high response rates in lymphoma

MD Anderson breaks ground on new Houston-area cancer center

Jeffrey Lee named chief medical executive at MD Anderson

Bhattacharya provides calm answers to anxious questions at confirmation hearingTrump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it